Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6520 | 1474 | 36.3 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
103 | 3 | O GLCNACYLATION//O GLCNAC TRANSFERASE//O GLCNACASE | 73436 |
1876 | 2 | RIBOSOME INACTIVATING PROTEIN//RICIN//TRICHOSANTHIN | 6016 |
6520 | 1 | IMMUNOTOXIN//GELONIN//RICIN A CHAIN | 1474 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | IMMUNOTOXIN | authKW | 482116 | 9% | 18% | 131 |
2 | GELONIN | authKW | 189358 | 2% | 38% | 24 |
3 | RICIN A CHAIN | authKW | 97086 | 1% | 25% | 19 |
4 | LIPOSOMAL RICIN | authKW | 82857 | 0% | 100% | 4 |
5 | IMMUNOCONJUGATE | authKW | 78069 | 2% | 13% | 29 |
6 | LIPOSOMAL MONENSIN | authKW | 62143 | 0% | 100% | 3 |
7 | MONOCLONAL ANTIBODY 80G | authKW | 62143 | 0% | 100% | 3 |
8 | REPROD 110 PINE AVE W | address | 50741 | 0% | 35% | 7 |
9 | ANTI B4 BLOCKED RICIN | authKW | 46606 | 0% | 75% | 3 |
10 | MISSILE THERAPY | authKW | 46606 | 0% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 9619 | 42% | 0% | 621 |
2 | Immunology | 3217 | 23% | 0% | 346 |
3 | Hematology | 1061 | 9% | 0% | 131 |
4 | Biochemical Research Methods | 408 | 6% | 0% | 95 |
5 | Biochemistry & Molecular Biology | 346 | 17% | 0% | 249 |
6 | Pharmacology & Pharmacy | 262 | 10% | 0% | 152 |
7 | Medicine, Research & Experimental | 129 | 5% | 0% | 69 |
8 | Transplantation | 83 | 2% | 0% | 29 |
9 | Biophysics | 79 | 4% | 0% | 56 |
10 | Chemistry, Medicinal | 49 | 3% | 0% | 37 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REPROD 110 PINE AVE W | 50741 | 0% | 35% | 7 |
2 | HEMATOL ONCOL UNIT COX 2 | 41429 | 0% | 100% | 2 |
3 | SELF ORGANISING SYST BIOPHYS | 39829 | 0% | 38% | 5 |
4 | SIMON FLAVELL LEUKAEMIA UNIT | 31068 | 0% | 50% | 3 |
5 | HORMONE BIOCHEM | 24046 | 0% | 19% | 6 |
6 | BIOCHEM CRC MOLEC TOXICOL GRP | 20714 | 0% | 100% | 1 |
7 | HONGO 731BUNKYO KU | 20714 | 0% | 100% | 1 |
8 | IDA M GREEN CANC | 20714 | 0% | 100% | 1 |
9 | IMMUNOL SECT DRUG TARGETING GRP 15 COTSWOLD RD | 20714 | 0% | 100% | 1 |
10 | MED MED PATHOL CANC | 20714 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 26768 | 5% | 2% | 75 |
2 | CANCER RESEARCH | 14372 | 11% | 0% | 165 |
3 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS | 10214 | 1% | 5% | 9 |
4 | CANCER DRUG DELIVERY | 8737 | 0% | 6% | 7 |
5 | BIOCONJUGATE CHEMISTRY | 7275 | 3% | 1% | 42 |
6 | CRC CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS | 3311 | 0% | 8% | 2 |
7 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 3282 | 1% | 1% | 18 |
8 | INTERNATIONAL JOURNAL OF CANCER | 3262 | 4% | 0% | 57 |
9 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 2706 | 1% | 2% | 8 |
10 | BRITISH JOURNAL OF CANCER | 2598 | 3% | 0% | 48 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IMMUNOTOXIN | 482116 | 9% | 18% | 131 | Search IMMUNOTOXIN | Search IMMUNOTOXIN |
2 | GELONIN | 189358 | 2% | 38% | 24 | Search GELONIN | Search GELONIN |
3 | RICIN A CHAIN | 97086 | 1% | 25% | 19 | Search RICIN+A+CHAIN | Search RICIN+A+CHAIN |
4 | LIPOSOMAL RICIN | 82857 | 0% | 100% | 4 | Search LIPOSOMAL+RICIN | Search LIPOSOMAL+RICIN |
5 | IMMUNOCONJUGATE | 78069 | 2% | 13% | 29 | Search IMMUNOCONJUGATE | Search IMMUNOCONJUGATE |
6 | LIPOSOMAL MONENSIN | 62143 | 0% | 100% | 3 | Search LIPOSOMAL+MONENSIN | Search LIPOSOMAL+MONENSIN |
7 | MONOCLONAL ANTIBODY 80G | 62143 | 0% | 100% | 3 | Search MONOCLONAL+ANTIBODY+80G | Search MONOCLONAL+ANTIBODY+80G |
8 | ANTI B4 BLOCKED RICIN | 46606 | 0% | 75% | 3 | Search ANTI+B4+BLOCKED+RICIN | Search ANTI+B4+BLOCKED+RICIN |
9 | MISSILE THERAPY | 46606 | 0% | 75% | 3 | Search MISSILE+THERAPY | Search MISSILE+THERAPY |
10 | CYTOTOXIC ANTI NEOPLASTIC POTENCY | 41429 | 0% | 100% | 2 | Search CYTOTOXIC+ANTI+NEOPLASTIC+POTENCY | Search CYTOTOXIC+ANTI+NEOPLASTIC+POTENCY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GILABERT-ORIOL, R , WENG, A , VON MALLINCKRODT, B , MELZIG, MF , FUCHS, H , THAKUR, M , (2014) IMMUNOTOXINS CONSTRUCTED WITH RIBOSOME-INACTIVATING PROTEINS AND THEIR ENHANCERS: A LETHAL COCKTAIL WITH TUMOR SPECIFIC EFFICACY.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 42. P. 6584 -6643 | 229 | 32% | 14 |
2 | BOLOGNESI, A , POLITO, L , (2004) IMMUNOTOXINS AND OTHER CONJUGATES: PRE-CLINICAL STUDIES.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 4. ISSUE 5. P. 563 -583 | 146 | 67% | 40 |
3 | FRACASSO, G , BELLISOLA, G , CASTELLETTI, D , TRIDENTE, G , COLOMBATTI, M , (2004) IMMUNOTOXINS AND OTHER CONJUGATES: PREPARATION AND GENERAL CHARACTERISTICS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 4. ISSUE 5. P. 545 -562 | 105 | 58% | 20 |
4 | KREITMAN, RJ , PASTAN, I , (1998) IMMUNOTOXINS FOR TARGETED CANCER THERAPY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 31. ISSUE 1-2. P. 53 -88 | 157 | 38% | 56 |
5 | GARNETT, MC , (2001) TARGETED DRUG CONJUGATES: PRINCIPLES AND PROGRESS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 53. ISSUE 2. P. 171 -216 | 82 | 45% | 168 |
6 | ENGERT, A , SAUSVILLE, EA , VITETTA, E , (1998) THE EMERGING ROLE OF RICIN A-CHAIN IMMUNOTOXINS IN LEUKEMIA AND LYMPHOMA.CLINICAL APPLICATIONS OF IMMUNOTOXINS. VOL. 234. ISSUE . P. 13 -33 | 70 | 68% | 19 |
7 | GHETIE, V , VITETTA, E , (1994) IMMUNOTOXINS IN THE THERAPY OF CANCER - FROM BENCH TO CLINIC.PHARMACOLOGY & THERAPEUTICS. VOL. 63. ISSUE 3. P. 209-234 | 77 | 71% | 30 |
8 | BLAKEY, DC , WAWRZYNCZAK, EJ , WALLACE, PM , THORPE, PE , (1988) ANTIBODY TOXIN CONJUGATES - A PERSPECTIVE.PROGRESS IN ALLERGY. VOL. 45. ISSUE . P. 50-90 | 101 | 65% | 43 |
9 | PIETERSZ, GA , ROWLAND, A , SMYTH, MJ , MCKENZIE, IFC , (1994) CHEMOIMMUNOCONJUGATES FOR THE TREATMENT OF CANCER.ADVANCES IN IMMUNOLOGY, VOLUME 56. VOL. 56. ISSUE . P. 301-387 | 104 | 40% | 27 |
10 | UPESLACIS, J , HINMAN, L , (1988) CHEMICAL MODIFICATION OF ANTIBODIES FOR CANCER-CHEMOTHERAPY.ANNUAL REPORTS IN MEDICINAL CHEMISTRY. VOL. 23. ISSUE . P. 151-160 | 68 | 81% | 20 |
Classes with closest relation at Level 1 |